Renishaw Neuro Solutions enables direct-to-target delivery for a broad range of applications. Using the neuroinfuse™ drug delivery system, predictable and translatable gene therapy infusions in preclinical and clinical trials can become a reality.
Our Lab2Clinic™ service supports pharma through the preclinical journey, translation into clinical trials and scaled-up commercialisation. We have a wide geographical reach and we focus on promoting long-term partnerships.
All this is underpinned by our FDA-cleared, CE-marked stereotactic products borne out of a +45-year precision engineering heritage.